These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 15735237)
21. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study. Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746 [TBL] [Abstract][Full Text] [Related]
22. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy. Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389 [TBL] [Abstract][Full Text] [Related]
23. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Farrar D; Tuffnell DJ; West J Cochrane Database Syst Rev; 2007 Jul; (3):CD005542. PubMed ID: 17636806 [TBL] [Abstract][Full Text] [Related]
24. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes. Danne T; Bangstad HJ; Deeb L; Jarosz-Chobot P; Mungaie L; Saboo B; Urakami T; Battelino T; Hanas R; Pediatr Diabetes; 2014 Sep; 15 Suppl 20():115-34. PubMed ID: 25182312 [No Abstract] [Full Text] [Related]
25. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes. González-Romero S; González-Molero I; Fernández-Abellán M; Domínguez-López ME; Ruiz-de-Adana S; Olveira G; Soriguer F Diabetes Technol Ther; 2010 Apr; 12(4):263-9. PubMed ID: 20210564 [TBL] [Abstract][Full Text] [Related]
33. Comment on Publications from OpT2mise Study. Milenkovic T; Kocova M; Krstevska B; Pemovska G; Smokovski I Diabetes Technol Ther; 2016 Jul; 18(7):446-7. PubMed ID: 27043789 [No Abstract] [Full Text] [Related]
34. Insulin therapy in children and adolescents with diabetes. Galli-Tsinopoulou A Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S114-7. PubMed ID: 21864742 [TBL] [Abstract][Full Text] [Related]
35. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues. Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931 [TBL] [Abstract][Full Text] [Related]
36. Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness. Rosenlund S; Theilade S; Hansen TW; Andersen S; Rossing P Acta Diabetol; 2014 Dec; 51(6):955-62. PubMed ID: 25274393 [TBL] [Abstract][Full Text] [Related]
37. Selecting an insulin program for type 1 diabetes. Scheiner G Diabetes Self Manag; 2003; 20(5):54-6, 58. PubMed ID: 14679953 [No Abstract] [Full Text] [Related]
38. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes. Weintrob N; Shalitin S; Phillip M Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365 [TBL] [Abstract][Full Text] [Related]
39. Diabetes Technology and the Human Factor. Liberman A; Barnard K Diabetes Technol Ther; 2018 Feb; 20(S1):S128-S138. PubMed ID: 29437474 [No Abstract] [Full Text] [Related]
40. Identifying patients for insulin pump therapy. Morrison G; Weston P Nurs Times; 2013 Mar 12-18; 109(10):14, 16, 18. PubMed ID: 23560341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]